EHMTI-0283. Predictors of early response to onabotulinumtoxin type a in chronic migraine

被引：0
|
作者：
N Mas-Sala
M Quintana
J Alvarez-Sabin
P Pozo-Rosich
机构：
[1] Hospital Universitari Vall d'Hebron,Neurology
来源：
The Journal of Headache and Pain | 2014年 / 15卷
关键词：
Migraine; Early Response; Chronic Migraine; Headache Frequency; Episodic Migraine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Type of pain and onabotulinumtoxin-A in chronic migraine: four years of follow-up
    Cesaretti, Chiara
    Molesti, Elisabetta
    Lolli, Francesco
    Amantini, Aldo
    Lori, Silvia
    JOURNAL OF HEADACHE AND PAIN, 2015, 16 : 1 - 2
  • [22] Predictors of Early Treatment Response in Patients with Chronic Migraine Receiving OnabotulinumtoxinA Injection Therapy
    Rothrock, J.
    Curreri, T.
    Andress-Rothrock, D.
    Lopez, J.
    HEADACHE, 2014, 54 (08): : 1429 - 1429
  • [23] Pharmacogenetics in chronic migraine: Role of CALCA and TRPV1 genes in therapeutic response to Onabotulinumtoxin A
    Moreno, R.
    Ruiz, M.
    Cernuda-Morollon, E.
    Gago-Veiga, A.
    Vidriales, I.
    de Sacristana Lopez-Serrano, M. M. Gallego
    Pascual, J.
    Telleria, J. J.
    Guerrero, A. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 25 - 25
  • [24] PREDICTORS OF RESPONSE TO BOTULINUM NEUROTOXIN (BONT) IN CHRONIC MIGRAINE
    Pozo-Rosich, Patricia
    TOXICON, 2018, 156 : S93 - S93
  • [25] EHMTI-0133. Does medication overuse matter? Response to botulinum toxin type A in chronic migraine in patients with or without medication overuse
    H Zafar
    M Khalil
    F Ahmed
    The Journal of Headache and Pain, 2014, 15
  • [26] Efficacy, safety, and predictors of response to botulinum toxin type A in refractory chronic migraine: A retrospective study
    Lin, Kuan-Hsiang
    Chen, Shih-Pin
    Fuh, Jong-Ling
    Wang, Yen-Feng
    Wang, Shuu-Jiun
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2014, 77 (01) : 10 - 15
  • [27] Long-term response to onabotulinumtoxin A in chronic migraine: analysis of efficacy and tolerability in a series of 40 patients
    Garcia-Azorin, D.
    Sierra, A.
    Trigo, J.
    Martinez-Pias, E.
    Guerrero, A. L.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [28] Neurophysiological, biomolecular and psychological predictors of response to Erenumab in chronic migraine
    Fiamingo, G.
    De Icco, R.
    Greco, R.
    Zanaboni, A. M.
    Bottiroli, S.
    Guaschino, E.
    Allena, M.
    Grillo, V.
    Tassorelli, C.
    Sancess, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 612 - 612
  • [29] Predictors of a negative response to topiramate therapy in patients with chronic migraine
    Rothrock, JF
    Parada, VA
    Drinkard, R
    Zweifler, RM
    Key, KE
    HEADACHE, 2005, 45 (07): : 932 - 935
  • [30] O034. Type of pain and onabotulinumtoxin-A in chronic migraine: four years of follow-up
    Chiara Cesaretti
    Elisabetta Molesti
    Francesco Lolli
    Aldo Amantini
    Silvia Lori
    The Journal of Headache and Pain, 2015, 16
12345